CN1582172A - 用贴片治疗口腔溃疡以加速痊愈和缓解疼痛的方法 - Google Patents
用贴片治疗口腔溃疡以加速痊愈和缓解疼痛的方法 Download PDFInfo
- Publication number
- CN1582172A CN1582172A CNA028220641A CN02822064A CN1582172A CN 1582172 A CN1582172 A CN 1582172A CN A028220641 A CNA028220641 A CN A028220641A CN 02822064 A CN02822064 A CN 02822064A CN 1582172 A CN1582172 A CN 1582172A
- Authority
- CN
- China
- Prior art keywords
- paster
- medicine
- glue
- ulcer
- dgl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002399 aphthous stomatitis Diseases 0.000 title claims abstract description 64
- 230000035876 healing Effects 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 70
- 238000000034 method Methods 0.000 claims abstract description 59
- 210000003296 saliva Anatomy 0.000 claims abstract description 27
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 claims abstract description 11
- 229960003022 amoxicillin Drugs 0.000 claims abstract description 11
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229930182555 Penicillin Natural products 0.000 claims abstract description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims abstract description 5
- 229940049954 penicillin Drugs 0.000 claims abstract description 5
- 210000000214 mouth Anatomy 0.000 claims description 61
- 208000007117 Oral Ulcer Diseases 0.000 claims description 52
- 239000003292 glue Substances 0.000 claims description 25
- 230000000844 anti-bacterial effect Effects 0.000 claims description 23
- 208000025865 Ulcer Diseases 0.000 claims description 22
- 231100000397 ulcer Toxicity 0.000 claims description 22
- 230000003203 everyday effect Effects 0.000 claims description 17
- 239000000853 adhesive Substances 0.000 claims description 16
- 230000001070 adhesive effect Effects 0.000 claims description 16
- 239000004615 ingredient Substances 0.000 claims description 16
- 241000202807 Glycyrrhiza Species 0.000 claims description 13
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 13
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 13
- 229940010454 licorice Drugs 0.000 claims description 13
- 229920002752 Konjac Polymers 0.000 claims description 11
- 230000003115 biocidal effect Effects 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 11
- 239000000252 konjac Substances 0.000 claims description 11
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 10
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 10
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 10
- 229920002581 Glucomannan Polymers 0.000 claims description 10
- 229920000159 gelatin Polymers 0.000 claims description 10
- 235000019322 gelatine Nutrition 0.000 claims description 10
- 229940046240 glucomannan Drugs 0.000 claims description 10
- 235000010485 konjac Nutrition 0.000 claims description 10
- 108010010803 Gelatin Proteins 0.000 claims description 9
- 229920000161 Locust bean gum Polymers 0.000 claims description 9
- 239000008273 gelatin Substances 0.000 claims description 9
- 235000011852 gelatine desserts Nutrition 0.000 claims description 9
- 235000010420 locust bean gum Nutrition 0.000 claims description 9
- 239000000711 locust bean gum Substances 0.000 claims description 9
- 235000010493 xanthan gum Nutrition 0.000 claims description 9
- 239000000230 xanthan gum Substances 0.000 claims description 9
- 229920001285 xanthan gum Polymers 0.000 claims description 9
- 229940082509 xanthan gum Drugs 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 241000241413 Propolis Species 0.000 claims description 6
- 229940069949 propolis Drugs 0.000 claims description 6
- 231100000862 numbness Toxicity 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 3
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 235000010419 agar Nutrition 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 238000009792 diffusion process Methods 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- SGRYPYWGNKJSDL-UHFFFAOYSA-N amlexanox Chemical compound NC1=C(C(O)=O)C=C2C(=O)C3=CC(C(C)C)=CC=C3OC2=N1 SGRYPYWGNKJSDL-UHFFFAOYSA-N 0.000 abstract description 6
- 229960003731 amlexanox Drugs 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 6
- 235000012054 meals Nutrition 0.000 abstract description 5
- 239000004599 antimicrobial Substances 0.000 abstract description 2
- 208000020670 canker sore Diseases 0.000 abstract 2
- 229940069445 licorice extract Drugs 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 12
- 208000007107 Stomach Ulcer Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000003826 tablet Substances 0.000 description 9
- 201000005917 gastric ulcer Diseases 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 7
- 229960004949 glycyrrhizic acid Drugs 0.000 description 7
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 7
- 235000019410 glycyrrhizin Nutrition 0.000 description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000004378 Glycyrrhizin Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000007937 lozenge Substances 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000590002 Helicobacter pylori Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940037467 helicobacter pylori Drugs 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 229920001169 thermoplastic Polymers 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical group CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 229960000520 diphenhydramine Drugs 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- -1 carbonyl diamine peroxide Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000002338 glycosides Chemical group 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 235000019823 konjac gum Nutrition 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Anesthesiology (AREA)
- Insects & Arthropods (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (55)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33291601P | 2001-11-05 | 2001-11-05 | |
US60/332,916 | 2001-11-05 | ||
US34457701P | 2001-12-28 | 2001-12-28 | |
US60/344,577 | 2001-12-28 | ||
US23628902A | 2002-09-04 | 2002-09-04 | |
US10/236,289 | 2002-09-04 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007100059664A Division CN101066257A (zh) | 2001-11-05 | 2002-11-05 | 用于治疗口腔溃疡的甘草根提取物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1582172A true CN1582172A (zh) | 2005-02-16 |
CN1309425C CN1309425C (zh) | 2007-04-11 |
Family
ID=27398834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028220641A Expired - Fee Related CN1309425C (zh) | 2001-11-05 | 2002-11-05 | 用贴片治疗口腔溃疡以加速痊愈和缓解疼痛的方法 |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP2338475A3 (zh) |
JP (2) | JP2005508980A (zh) |
CN (1) | CN1309425C (zh) |
AU (2) | AU2009217366A1 (zh) |
CA (1) | CA2466061A1 (zh) |
HK (1) | HK1073802A1 (zh) |
WO (1) | WO2003039465A2 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1850059B (zh) * | 2006-05-29 | 2010-05-12 | 王法平 | 氨来呫诺口腔膜剂及其制备方法 |
CN101138541B (zh) * | 2006-09-06 | 2010-10-06 | 上海医药工业研究院 | 氨来占诺局部成膜凝胶组合物及其应用 |
CN108904460A (zh) * | 2012-02-19 | 2018-11-30 | 奥拉黑尔斯公司 | 用于口腔粘附圆片的碱化金合欢树胶粘合剂 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7201930B2 (en) | 2001-11-05 | 2007-04-10 | Haley Jeffrey T | Licorice root extract oral patch for treating canker sores |
JP2005508980A (ja) * | 2001-11-05 | 2005-04-07 | オラヘルス コーポレーション | 治癒を促進し、痛みを緩和させるパッチによる口内炎治療法 |
JP2006096728A (ja) * | 2004-09-30 | 2006-04-13 | Kobayashi Pharmaceut Co Ltd | 口腔内定着型固形製剤 |
US20070243238A1 (en) * | 2006-04-13 | 2007-10-18 | Haley Jeffrey T | Treating mouth sores with patches adhered to teeth |
EP2181721A3 (de) * | 2006-11-06 | 2010-05-19 | Lohmann & Rauscher GmbH & Co. KG | Produkt zur Versorgung von Entzündungen, Druckstellen und/oder Aphten im Oralbereich sowie Verwendung eines solchen Produkts |
JP2008208088A (ja) * | 2007-02-27 | 2008-09-11 | Ehime Univ | 口内炎処置用組成物 |
EP2742931A1 (de) * | 2012-12-13 | 2014-06-18 | LTS LOHMANN Therapie-Systeme AG | Topisches Arzneimittel zur Behandlung von Aphten |
CN107802641A (zh) * | 2016-09-09 | 2018-03-16 | 李明典 | 口腔软组织(牙龈、粘膜)抗发炎酸痛剂 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3046195A (en) | 1957-03-14 | 1962-07-24 | Gerardus Van Loon | Process for deglycyrrhizinating licorice |
IL65184A0 (en) * | 1982-03-05 | 1982-05-31 | Yissum Res Dev Co | Preparation for the treatment of oral diseases,comprising glycyrrhizin |
US5362737A (en) * | 1991-04-09 | 1994-11-08 | Chemex Pharmaceuticals, Inc. | Methods of treating aphthous ulcers and other mucocutaneous disorders with amlexanox |
JP2609564B2 (ja) * | 1991-05-31 | 1997-05-14 | 政夫 斎藤 | アレルギー性皮膚炎用クリーム及びその製造方法 |
US5198217A (en) * | 1991-09-24 | 1993-03-30 | Choice Pharmaceuticals | Topical demulcent for viral and inflammatory diseases of the skin |
JP3350678B2 (ja) * | 1992-02-27 | 2002-11-25 | 株式会社ダイゾー | 口腔用エアゾール製品 |
US5409703A (en) * | 1993-06-24 | 1995-04-25 | Carrington Laboratories, Inc. | Dried hydrogel from hydrophilic-hygroscopic polymer |
US5713852A (en) | 1995-06-07 | 1998-02-03 | Alza Corporation | Oral dosage and method for treating painful conditions of the oral cavity |
US5849322A (en) * | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
TW452494B (en) * | 1996-03-12 | 2001-09-01 | Jang De Shan | Herbal composition for stimulating blood circulation |
HUP0002490A2 (hu) * | 1997-07-23 | 2000-12-28 | Perio Products Ltd. | Csersav-polimer kompozíciók gyógyászati anyagok szabályozott leadására, különösen a szájüregben |
JPH11197217A (ja) * | 1998-01-12 | 1999-07-27 | Kanae Kagawa:Kk | 速溶性ディスポ口腔用材 |
US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
US6248718B1 (en) | 1999-08-18 | 2001-06-19 | Atlantic Biomed Corporation | Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity |
JP2001089346A (ja) * | 1999-09-24 | 2001-04-03 | We'll Corporation:Kk | 口腔用組成物 |
DE10038571A1 (de) * | 2000-08-03 | 2002-02-14 | Knoll Ag | Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen |
JP2005508980A (ja) * | 2001-11-05 | 2005-04-07 | オラヘルス コーポレーション | 治癒を促進し、痛みを緩和させるパッチによる口内炎治療法 |
US20070048369A1 (en) * | 2005-08-26 | 2007-03-01 | National Starch And Chemical Investment Holding Corporation | Mucosal delivery tablet |
-
2002
- 2002-11-05 JP JP2003541757A patent/JP2005508980A/ja active Pending
- 2002-11-05 EP EP10192668A patent/EP2338475A3/en not_active Withdrawn
- 2002-11-05 CN CNB028220641A patent/CN1309425C/zh not_active Expired - Fee Related
- 2002-11-05 EP EP02791205A patent/EP1446167A4/en not_active Withdrawn
- 2002-11-05 WO PCT/US2002/035399 patent/WO2003039465A2/en active Application Filing
- 2002-11-05 CA CA002466061A patent/CA2466061A1/en not_active Abandoned
-
2005
- 2005-07-25 HK HK05106307A patent/HK1073802A1/xx not_active IP Right Cessation
-
2009
- 2009-09-17 AU AU2009217366A patent/AU2009217366A1/en not_active Abandoned
- 2009-09-17 AU AU2009217365A patent/AU2009217365A1/en not_active Abandoned
-
2010
- 2010-03-12 JP JP2010055534A patent/JP2010163451A/ja active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1850059B (zh) * | 2006-05-29 | 2010-05-12 | 王法平 | 氨来呫诺口腔膜剂及其制备方法 |
CN101138541B (zh) * | 2006-09-06 | 2010-10-06 | 上海医药工业研究院 | 氨来占诺局部成膜凝胶组合物及其应用 |
CN108904460A (zh) * | 2012-02-19 | 2018-11-30 | 奥拉黑尔斯公司 | 用于口腔粘附圆片的碱化金合欢树胶粘合剂 |
Also Published As
Publication number | Publication date |
---|---|
WO2003039465A3 (en) | 2003-11-20 |
AU2009217366A1 (en) | 2009-10-08 |
JP2010163451A (ja) | 2010-07-29 |
EP2338475A3 (en) | 2012-08-08 |
EP2338475A2 (en) | 2011-06-29 |
AU2009217365A1 (en) | 2009-10-08 |
HK1073802A1 (en) | 2005-10-21 |
EP1446167A2 (en) | 2004-08-18 |
WO2003039465A2 (en) | 2003-05-15 |
EP1446167A4 (en) | 2010-09-29 |
CN1309425C (zh) | 2007-04-11 |
CA2466061A1 (en) | 2003-05-15 |
JP2005508980A (ja) | 2005-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5686094A (en) | Controlled release formulations for the treatment of xerostomia | |
EP1357870B1 (en) | Bioadhesive cell foam film of sustained-release delivery | |
AU2009217366A1 (en) | Treating canker sores with patches to speed healing and relieve pain | |
JPS6318923B2 (zh) | ||
CA2702614A1 (en) | Composition for administering an active ingredient and method for making and using the same | |
WO2004043351A2 (en) | Soluble oral patch with collagen and interlaced active ingredients | |
EP0497956B1 (en) | Controlled release formulations | |
CN101466369B (zh) | 在牙齿或正畸牙套上使用的带凹陷的粘附性贴剂 | |
US7201930B2 (en) | Licorice root extract oral patch for treating canker sores | |
US20210220292A1 (en) | Cannabinoid and anesthetic compositions and methods | |
JP2005508980A5 (zh) | ||
US10966924B2 (en) | Veterinary cannabinoid, menthol and anesthetic compositions and methods | |
CN100384407C (zh) | 一种中药口腔粘贴片及其制备 | |
CN1686211A (zh) | 治疗急慢性咽喉炎、复发性口腔溃疡的药物及制备方法 | |
CN101066257A (zh) | 用于治疗口腔溃疡的甘草根提取物 | |
CN1795858A (zh) | 盐酸罗沙替丁醋酸酯口服片剂 | |
EP1567102A2 (en) | Soluble oral patch with collagen and interlaced active ingredients | |
CN1108160C (zh) | 一种治疗口腔溃疡的药物及制备方法 | |
CN112245411B (zh) | 一种普适性口腔绷带及其制备方法 | |
CN1030184A (zh) | 炎立消的制造方法 | |
AU2002363325A1 (en) | Treating canker sores with patches to speed healing and relieve pain | |
CN101433576A (zh) | 小儿止泻药膏 | |
CN1289144C (zh) | 治疗放射性黏膜损伤、复发性口疮、牙周炎的药物 | |
CN118304280A (zh) | 一种复合***植物纤维精油缓释贴片及其制备和应用 | |
CN112353825A (zh) | 一种治疗口腔溃疡的中药双层贴片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1073802 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ALRONIZ INTERNATIONAL CO., LTD. Free format text: FORMER OWNER: ORAHEALTH CORP. Effective date: 20070727 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070727 Address after: Washington State Patentee after: Haley Jeffrey T. Address before: Washington State Patentee before: Orahealth Corp. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070411 Termination date: 20131105 |